161 related articles for article (PubMed ID: 8035998)
1. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
[TBL] [Abstract][Full Text] [Related]
2. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
3. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
5. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
6. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
[TBL] [Abstract][Full Text] [Related]
8. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
[TBL] [Abstract][Full Text] [Related]
9. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
10. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
11. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
12. Functional duality of merlin: a conundrum of proteome complexity.
Chen Z; Fadiel A; Xia Y
Med Hypotheses; 2006; 67(5):1095-8. PubMed ID: 16824698
[TBL] [Abstract][Full Text] [Related]
13. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
[TBL] [Abstract][Full Text] [Related]
14. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
15. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
Stokowski RP; Cox DR
Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
[TBL] [Abstract][Full Text] [Related]
17. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
Lutchman M; Rouleau GA
Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
[TBL] [Abstract][Full Text] [Related]
18. The tumour suppressor protein NF2/merlin: the puzzle continues.
Hovens CM; Kaye AH
J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.
den Bakker MA; Tascilar M; Riegman PH; Hekman AC; Boersma W; Janssen PJ; de Jong TA; Hendriks W; van der Kwast TH; Zwarthoff EC
Am J Pathol; 1995 Nov; 147(5):1339-49. PubMed ID: 7485397
[TBL] [Abstract][Full Text] [Related]
20. Expression of NF2 gene product merlin in arachnoid villi and meningiomas.
Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J
Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
